Table of Contents

Although we often approach anticoagulation therapy with a confidence born of familiarity, it is not for the faint of heart.

Whether to resume anticoagulant therapy after an intracerebral hemorrhage requires careful consideration of many factors, including patient preferences and tolerance of different levels of risk.

Starting a bisphosphonate too soon after surgery could disrupt bone remodeling and delay fracture repair.

Recent studies and trials regarding bone loss, dialysis outcomes, dementia, and other topics.

In selected patients, the potential benefit of resuming anticoagulation outweighs the considerable risk.

Confronted with a low TSH level, physicians should not jump to the conclusion that it is due to a hyperthyroid state.

The 2009 pandemic of influenza A (H1N1) was less severe than some others, thanks in part to advances in diagnosis, treatment, and public health.

Children born with tetralogy of Fallot and other congenital heart defects are living longer—long enough, eventually, to present to your clinic.

Readers comment on preventing glucocorticoid-induced osteoporosis (August 2010) and on electronic medical records (July 2010).